Group 1 - Reservoir Media, Inc. reported a quarterly loss of $0.01 per share, consistent with the Zacks Consensus Estimate, and the same loss as the previous year [1] - The company posted revenues of $37.16 million for the quarter ended June 2025, exceeding the Zacks Consensus Estimate by 2.47%, and up from $34.32 million year-over-year [2] - Reservoir Media shares have declined approximately 13.7% since the beginning of the year, contrasting with the S&P 500's gain of 7.6% [3] Group 2 - The earnings outlook for Reservoir Media is mixed, with the current consensus EPS estimate at $0.05 on revenues of $43.22 million for the upcoming quarter, and $0.16 on revenues of $166.56 million for the current fiscal year [7] - The Zacks Industry Rank indicates that the Media Conglomerates sector is in the bottom 27% of over 250 Zacks industries, suggesting potential challenges for stock performance [8] Group 3 - The estimate revisions trend for Reservoir Media was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Financial Performance - Ocular Therapeutix reported a quarterly loss of $0.39 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.35, and compared to a loss of $0.24 per share a year ago, indicating a decline in performance [1] - The company posted revenues of $13.46 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 0.7%, and down from $16.44 million in the same quarter last year [2] - Over the last four quarters, Ocular Therapeutix has not surpassed consensus EPS estimates and has topped revenue estimates only once [2] Stock Performance - Ocular Therapeutix shares have increased by approximately 44.6% since the beginning of the year, significantly outperforming the S&P 500's gain of 7.6% [3] - The stock currently holds a Zacks Rank 5 (Strong Sell), indicating expectations of underperformance in the near future [6] Future Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.34 on revenues of $14.99 million, and for the current fiscal year, it is -$1.42 on revenues of $56.55 million [7] - The estimate revisions trend for Ocular Therapeutix was unfavorable ahead of the earnings release, which may impact future stock movements [6] Industry Context - The Medical - Drugs industry, to which Ocular Therapeutix belongs, is currently ranked in the top 37% of over 250 Zacks industries, suggesting a relatively strong industry performance [8] - Another company in the same industry, Plus Therapeutics, is expected to report a quarterly loss of $0.09 per share, reflecting a year-over-year change of +87.3%, with revenues projected to be $1.7 million, up 32.8% from the previous year [9]

Financial Performance - EVgo Inc. reported a quarterly loss of $0.1 per share, which was better than the Zacks Consensus Estimate of a loss of $0.13, representing an earnings surprise of +23.08% [1] - The company posted revenues of $98.03 million for the quarter ended June 2025, exceeding the Zacks Consensus Estimate by 13.80%, compared to revenues of $66.62 million a year ago [2] - Over the last four quarters, EVgo has surpassed consensus EPS estimates three times and topped consensus revenue estimates three times [2] Stock Performance - EVgo shares have declined approximately 12.8% since the beginning of the year, while the S&P 500 has gained 7.6% [3] - The current Zacks Rank for EVgo is 3 (Hold), indicating that the shares are expected to perform in line with the market in the near future [6] Future Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.14 on revenues of $91.68 million, and for the current fiscal year, it is -$0.44 on revenues of $354.7 million [7] - The outlook for the automotive industry, where EVgo operates, is currently in the top 35% of over 250 Zacks industries, suggesting a favorable environment for performance [8]

Core Insights - LGI Homes reported quarterly earnings of $1.36 per share, exceeding the Zacks Consensus Estimate of $1.21 per share, but down from $2.48 per share a year ago [1] - The earnings surprise was +12.40%, while the previous quarter saw a significant miss with actual earnings of $0.46 compared to an expected $0.75, resulting in a surprise of -38.67% [2] - The company generated revenues of $483.49 million for the quarter, surpassing the Zacks Consensus Estimate by 1.14%, but down from $602.5 million year-over-year [3] Earnings Outlook - The future performance of LGI Homes' stock will largely depend on management's commentary during the earnings call and the sustainability of the recent price movements [4] - The stock has underperformed the market, losing about 38.9% year-to-date compared to the S&P 500's gain of 7.6% [4] - Current consensus EPS estimate for the upcoming quarter is $2.06 on revenues of $630.67 million, and for the current fiscal year, it is $5.83 on revenues of $2.16 billion [8] Industry Context - The Real Estate - Development industry, to which LGI Homes belongs, is currently ranked in the top 28% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [9] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [6] - The unfavorable trend in estimate revisions prior to the earnings release has resulted in a Zacks Rank 5 (Strong Sell) for LGI Homes, indicating expected underperformance in the near future [7]

Company Performance - Foghorn Therapeutics Inc. reported a quarterly loss of $0.28 per share, which was better than the Zacks Consensus Estimate of a loss of $0.31, and an improvement from a loss of $0.45 per share a year ago, representing an earnings surprise of +9.68% [1] - The company posted revenues of $7.56 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 0.85%, but showing an increase from year-ago revenues of $6.89 million [2] - Over the last four quarters, Foghorn Therapeutics has surpassed consensus EPS estimates two times, but has not been able to beat consensus revenue estimates [2] Market Outlook - Foghorn Therapeutics shares have increased by approximately 8.9% since the beginning of the year, outperforming the S&P 500's gain of 7.6% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the coming quarter is -$0.31 on revenues of $7.93 million, and for the current fiscal year, it is -$1.27 on revenues of $29.82 million [7] Industry Context - The Medical - Biomedical and Genetics industry, to which Foghorn Therapeutics belongs, is currently ranked in the bottom 43% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact investor decisions [5]

Core Insights - Marriott International reported quarterly earnings of $2.65 per share, exceeding the Zacks Consensus Estimate of $2.64 per share, and showing an increase from $2.50 per share a year ago, resulting in an earnings surprise of +0.38% [1] - The company generated revenues of $6.74 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.17% and reflecting a year-over-year increase from $6.44 billion [2] - The stock has underperformed the market, losing about 7.1% since the beginning of the year compared to the S&P 500's gain of 7.6% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $2.49 on revenues of $6.51 billion, while for the current fiscal year, the estimate is $9.99 on revenues of $26.16 billion [7] - The trend of estimate revisions for Marriott was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Hotels and Motels industry is currently in the bottom 10% of the Zacks Industry Rank, which suggests that stocks in the top 50% of Zacks-ranked industries outperform those in the bottom 50% by more than 2 to 1 [8] - Another company in the same industry, Soho House & Co, is expected to report a quarterly loss of $0.08 per share, reflecting a year-over-year change of +52.9%, with revenues projected at $309 million, up 1.3% from the previous year [9]

Core Insights - Life Time Group Holdings, Inc. (LTH) reported quarterly earnings of $0.37 per share, exceeding the Zacks Consensus Estimate of $0.33 per share, and up from $0.25 per share a year ago, representing an earnings surprise of +12.12% [1] - The company achieved revenues of $761.47 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.27% and increasing from $667.76 million year-over-year [2] - Life Time Group Holdings shares have increased approximately 29.3% year-to-date, significantly outperforming the S&P 500's gain of 7.6% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.32 on revenues of $769.91 million, and for the current fiscal year, it is $1.32 on revenues of $2.97 billion [7] - The estimate revisions trend for Life Time Group Holdings was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Leisure and Recreation Services industry, to which Life Time Group Holdings belongs, is currently ranked in the bottom 29% of over 250 Zacks industries, suggesting potential challenges ahead [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact investor sentiment [5]

Core Insights - Zebra Technologies (ZBRA) reported quarterly earnings of $3.61 per share, exceeding the Zacks Consensus Estimate of $3.31 per share, and up from $3.18 per share a year ago [1] - The earnings surprise for the quarter was +9.06%, and the company has surpassed consensus EPS estimates in all four of the last quarters [2] - Zebra's revenues for the quarter reached $1.29 billion, surpassing the Zacks Consensus Estimate by 1.17% and increasing from $1.22 billion year-over-year [3] Financial Performance - The company has consistently exceeded consensus revenue estimates over the last four quarters [3] - The current consensus EPS estimate for the upcoming quarter is $3.24, with expected revenues of $1.28 billion, and for the current fiscal year, the EPS estimate is $14.51 on revenues of $5.23 billion [8] Market Position - Zebra shares have underperformed the market, losing about 11.6% since the beginning of the year, while the S&P 500 has gained 7.6% [4] - The Zacks Industry Rank for Manufacturing - Thermal Products is in the top 41% of over 250 Zacks industries, indicating a favorable position within the sector [9] Future Outlook - The earnings outlook and estimate revisions will be crucial for Zebra's stock performance moving forward [5][6] - The current Zacks Rank for Zebra is 3 (Hold), suggesting that the shares are expected to perform in line with the market in the near future [7]

Core Insights - Clear Channel Outdoor (CCO) reported a quarterly loss of $0.04 per share, consistent with the Zacks Consensus Estimate, and an improvement from a loss of $0.06 per share a year ago [1] - The company generated revenues of $402.81 million for the quarter ended June 2025, exceeding the Zacks Consensus Estimate by 0.80%, but down from $558.54 million year-over-year [2] - CCO's stock has declined approximately 19.7% year-to-date, contrasting with the S&P 500's gain of 7.6% [3] Earnings Outlook - The future performance of CCO's stock will largely depend on management's commentary during the earnings call and the earnings outlook [4] - The current consensus EPS estimate for the upcoming quarter is -$0.05 on revenues of $390.4 million, and for the current fiscal year, it is $0.02 on revenues of $1.57 billion [7] Industry Context - The Advertising and Marketing industry, to which CCO belongs, is currently ranked in the top 32% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked using tools like the Zacks Rank [5][6]

Clear Secure (YOU) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.34 per share a year ago. These figures are adjusted for non- recurring items. This quarterly report represents an earnings surprise of +13.04%. A quarter ago, it was expected that this airport security company would post earnings of $0.3 per share when it actually produced earnings of $0.32, delivering a surprise of +6.67%. Over the last four quarte ...